Elixinol Wellness Limited Stock Fundamentals
| E8M Stock | EUR 0 0.00 0.00% |
Elixinol Wellness Limited fundamentals help investors to digest information that contributes to Elixinol Wellness' financial success or failures. It also enables traders to predict the movement of Elixinol Stock. The fundamental analysis module provides a way to measure Elixinol Wellness' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elixinol Wellness stock.
Elixinol |
Elixinol Wellness Limited Company Operating Margin Analysis
Elixinol Wellness' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Elixinol Wellness Operating Margin | (1.63) % |
Most of Elixinol Wellness' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elixinol Wellness Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Elixinol Wellness Limited has an Operating Margin of -1.6331%. This is 95.34% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all Germany stocks is 70.36% lower than that of the firm.
Elixinol Wellness Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Elixinol Wellness's current stock value. Our valuation model uses many indicators to compare Elixinol Wellness value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elixinol Wellness competition to find correlations between indicators driving Elixinol Wellness's intrinsic value. More Info.Elixinol Wellness Limited is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elixinol Wellness' earnings, one of the primary drivers of an investment's value.Elixinol Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elixinol Wellness' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Elixinol Wellness could also be used in its relative valuation, which is a method of valuing Elixinol Wellness by comparing valuation metrics of similar companies.Elixinol Wellness is currently under evaluation in operating margin category among its peers.
Elixinol Fundamentals
| Return On Equity | -0.71 | |||
| Return On Asset | -0.33 | |||
| Profit Margin | (1.72) % | |||
| Operating Margin | (1.63) % | |||
| Current Valuation | 1.96 M | |||
| Shares Outstanding | 316.27 M | |||
| Shares Owned By Insiders | 15.67 % | |||
| Shares Owned By Institutions | 4.83 % | |||
| Price To Book | 0.54 X | |||
| Price To Sales | 0.50 X | |||
| Revenue | 7.05 M | |||
| Gross Profit | 4.9 M | |||
| EBITDA | (9.28 M) | |||
| Net Income | (10.57 M) | |||
| Cash And Equivalents | 27.74 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 250 K | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 7.08 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (14.07 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 16 | |||
| Beta | 1.71 | |||
| Market Capitalization | 5.08 M | |||
| Total Asset | 13.48 M | |||
| Z Score | 12.0 | |||
| Net Asset | 13.48 M |
About Elixinol Wellness Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elixinol Wellness Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elixinol Wellness using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elixinol Wellness Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. The company was incorporated in 2017 and is headquartered in Sydney, Australia. ELIXINOL GLOBAL operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Elixinol Stock
Elixinol Wellness financial ratios help investors to determine whether Elixinol Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elixinol with respect to the benefits of owning Elixinol Wellness security.